The research, led by Chenjing Zhang and colleagues at Fujian Agriculture and Forestry University, focused on 20-hydroxyecdysone, or 20E, the major bioactive ecdysteroid produced by A. bidentata. Ecdysteroids are best known as the molting hormones of insects, but plants in the Amaranthaceae family synthesize them in remarkable quantities, and their ecological roles have remained only partially understood. What made 20E a compelling suspect in the continuous-cropping mystery was its documented capacity to influence microbial growth: it can stimulate beneficial bacteria and, intriguingly, affect the potentially pathogenic fungus Fusarium oxysporum, a soil dweller responsible for devastating wilt diseases in countless crops worldwide. The team hypothesized that the plant’s ability to thrive under repeated cultivation might hinge on how much 20E it pumps into its root zone.

To trace the pathway from gene to ecosystem, the investigators combined three complementary approaches: field association analysis across plots with different durations of continuous cropping, functional manipulation of a candidate biosynthetic gene, and controlled experiments with purified 20E and root exudates. The field surveys delivered the first crucial pattern. As continuous cropping stretched over multiple years, 20E accumulation in the plant rose in tandem with increasing abundances of two bacterial genera, Bacillus and Pseudomonas, both widely recognized as plant-beneficial groups capable of suppressing disease and promoting growth. Strikingly, Fusarium oxysporum showed no sustained accumulation in these long-term plots, defying the expectation that a pathogenic fungus would flourish as monoculture continues.

Correlation analysis sharpened this picture considerably. Traits related to 20E were positively associated with the abundances of the beneficial bacteria and negatively associated with F. oxysporum. In other words, the more 20E the system contained, the more the rhizosphere tilted toward a protective microbial assembly and away from a disease-prone one. This statistical signature suggested, but did not prove, a causal chain running from the plant’s sterol metabolism through 20E production to the composition of its microbial entourage. Establishing that chain required identifying and manipulating the enzyme at the top of the pathway.

That enzyme is sterol Δ7-reductase, known as DHCR7, a key player in sterol biosynthesis that shapes the sterol composition of cells. Because sterols provide the precursor backbone from which ecdysteroids like 20E are built, DHCR7 sits at a critical regulatory junction. The team identified, for the first time in A. bidentata, two paralogous copies of the gene, which they named AbDHCR7-1 and AbDHCR7-2. Both copies were significantly induced by long-term continuous cropping, hinting that the plant ramps up its sterol-processing machinery precisely when the soil environment becomes most challenging, a response consistent with metabolic adaptation rather than decline.

The functional experiments then delivered the study’s most dramatic numbers. When the researchers overexpressed AbDHCR7-1 in hairy root cultures, 20E contents surged by 222 percent compared with controls; overexpression of AbDHCR7-2 produced a 111 percent increase. The root exudates, the chemical cocktail that roots release into the surrounding soil, also showed a tendency toward higher 20E levels in the overexpression lines, meaning the hormone was not merely accumulating inside the tissue but was being exported into the rhizosphere where microbes would encounter it. Conversely, when the team used virus-induced gene silencing to knock down AbDHCR7 expression, 20E accumulation dropped. The dose-response relationship between the gene and the metabolite was now firmly established in both directions.

The decisive test came in soil. In a controlled pot experiment using substrate taken from the one-year continuous-cropping field treatment, the researchers applied hairy-root exudates harvested from the overexpression lines. The result was a measurable shift in the soil community: rhizosphere abundances of Bacillus and Pseudomonas increased significantly, while the abundance of F. oxysporum decreased. This experiment connected the molecular manipulation directly to ecological outcomes, demonstrating that a plant’s engineered metabolic output, delivered through its natural exudation channels, could restructure the microbial neighborhood in a direction favorable to the plant. It is the kind of host-driven microbiome management that microbiologists have theorized about but rarely documented with such a complete chain of evidence.

Complementary assays filled in the mechanistic details of how individual microbes respond to 20E itself. Exogenous 20E treatment and in vitro culture experiments showed differential responses among the targeted organisms: the beneficial bacteria responded positively to the compound, growing and enriching in its presence, whereas F. oxysporum exhibited an inhibitory response. This selectivity is what makes the system so elegant from the plant’s perspective. A single exported metabolite acts simultaneously as a lure for allies and a deterrent for an enemy, achieving through chemistry what many crops cannot achieve even with intensive agricultural intervention. The differential sensitivity also suggests that the microbial community structure under long-term cropping is not a random byproduct of soil fatigue but an actively sculpted outcome of host metabolism.

The broader implications of the work extend in two directions. For the study of medicinal plants, it provides the first functional link between a DHCR7 enzyme and 20E accumulation in A. bidentata, opening the possibility of breeding or engineering varieties with optimized ecdysteroid profiles, both for pharmacological yield and for soil resilience. For agriculture at large, it offers a template for rhizosphere microbiome management based on host-specific metabolites rather than external inputs such as pesticides or microbial inoculants. If crops could be tuned to exude the right compounds at the right times, the soil itself might be enlisted as a partner in disease suppression. The authors note that their findings provide a basis for further understanding the mechanisms underlying continuous-cropping adaptation in medicinal plants, and the field system they describe, spanning multiple years of repeated cultivation, offers a rare natural experiment in how a plant and its microbial partners co-evolve under sustained monoculture pressure.

There is also a conceptual lesson in the study’s reversal of expectations. Continuous cropping is conventionally framed as a story of degradation: nutrients deplete, pathogens accumulate, and microbial diversity collapses. A. bidentata demonstrates that the trajectory can run differently when the host possesses the right metabolic machinery. By upregulating sterol metabolism under stress, the plant converts an increasingly hostile soil environment into an increasingly selective one, filtering its microbial associates through the lens of 20E. Whether similar mechanisms operate in other ecdysteroid-producing species, or whether the principle can be transferred to crops that lack such chemistry, remains an open question. But the demonstration that a single biosynthetic gene can ripple outward from sterol composition to hormone export to bacterial enrichment and fungal suppression marks a significant step toward understanding plants not as passive victims of their soil, but as active architects of the living world that surrounds their roots.

Subject of Research: Regulation of 20-hydroxyecdysone biosynthesis by AbDHCR7 and its effects on rhizosphere microbial communities in Achyranthes bidentata under continuous cropping

Article Title: AbDHCR7 regulates 20-hydroxyecdysone accumulation in Achyranthes bidentata and contributes to differential responses of targeted rhizosphere microorganisms

Article References: Zhang, C., Zhang, B., Zhang, S., Chen, Y., Zhang, M., Li, J., Zeng, C., Fang, Z., Zhong, S., Jiao, Y., Xu, H., Qin, B., Chen, T., Lin, S., Liu, Y., Fang, C., & Lin, W. (2026). AbDHCR7 regulates 20-hydroxyecdysone accumulation in Achyranthes bidentata and contributes to differential responses of targeted rhizosphere microorganisms. BMC Plant Biology. https://doi.org/10.1186/s12870-026-10100-z

Image Credits: AI Generated

DOI: 10.1186/s12870-026-10100-z

Keywords: Achyranthes bidentata, AbDHCR7, 20-hydroxyecdysone, rhizosphere microbiome, continuous cropping, root exudates, Bacillus, Pseudomonas, Fusarium oxysporum, sterol biosynthesis, medicinal plants, plant-microbe interactions

Organoid technology has reshaped regenerative medicine by moving beyond flat cell culture toward self-organized three-dimensional microtissues that better reproduce native tissue architecture and function. Unlike conventional two-dimensional cultures, bone organoids preserve cell-cell communication, cell-matrix interactions, lineage patterning, and extracellular matrix remodeling within a spatially relevant environment. Recent years have seen skeletal organoid systems expand to include bone marrow-like, trabecular-like, callus-like, and woven-bone-like constructs, with matrix engineering and biofabrication enabling tighter control of geometry and maturation. Yet the field still confronts key barriers, including inadequate vascularization, immature mechanics, diffusion limitations in larger constructs, and the absence of standardized bioactive programming. In this study, the term bone organoids refers specifically to bone marrow stromal cell-derived three-dimensional osteogenic microtissues that reproduce selected features of bone formation, including cell-cell interaction, matrix production, and mineral deposition, rather than fully vascularized or marrow-containing bone equivalents.

Achyranthes bidentata, the botanical source of a traditional Chinese medicine, emerged as an attractive candidate for biofunctionalizing such constructs. Pharmacognostic studies identify multiple bioactive constituents in the plant, including polysaccharides, saponins, steroids, and related small molecules, and toxicology work suggests a favorable safety profile at therapeutic doses. Experimental evidence supports a direct role in skeletal repair: AB saponins promote osteogenic differentiation of bone marrow stromal cells through the ERK/MAPK pathway, osteoblast studies show enhanced proliferation and Runx2-associated osteogenic activity after treatment, and purified polysaccharide fractions exhibit in vitro osteogenic activity. In parallel, AB regulates the resorptive arm of bone remodeling, with prior studies demonstrating suppression of osteoclastogenesis through inhibition of RANKL signaling and osteoprotective effects in vivo through regulation of the RANKL/RANK/OPG axis. This dual anabolic and anti-resorptive potential is precisely the type of combined cue needed for functional bone regeneration, yet until now AB research and organoid engineering had largely progressed in parallel.

The research team, led by Chenxing Lu and colleagues, designed a four-stage workflow: dose screening of AB in rat bone marrow-derived mesenchymal stromal cells, generation and characterization of AB-bone organoids, evaluation in a critical-sized calvarial defect model, and an exploratory retrospective clinical analysis of AB exposure in tibial fracture healing. The botanical material was authenticated by macroscopic and microscopic examination according to the Pharmacopoeia of the People’s Republic of China, with voucher specimens deposited at the Institute of Chinese Materia Medica. Dried roots were decocted with distilled water, filtered, concentrated, and lyophilized to an 18.5 percent extraction yield, then characterized by high-performance liquid chromatography fingerprinting to establish batch traceability before any biological testing began.

Dose screening revealed a concentration-dependent osteopromotive window. Bone marrow stromal cells exposed to graded concentrations from 0 to 400 micrograms per milliliter showed good cytocompatibility at low and intermediate doses, with cell viability and proliferative activity rising steadily up to 200 micrograms per milliliter, the concentration that produced peak alkaline phosphatase activity and Alizarin Red S-detected mineralization. At 400 micrograms per milliliter, the proliferative benefit was attenuated, indicating that the effect was concentration dependent rather than linearly cumulative. Quantitative PCR confirmed that AB markedly upregulated the osteogenic program, increasing expression of Col1a1, Runx2, Opn, and Ocn. Mechanistic experiments using PD98059, a selective ERK/MAPK pathway inhibitor, showed that AB increased ERK1/2 phosphorylation and that blocking the pathway partially attenuated AB-enhanced alkaline phosphatase activity and mineralized matrix formation, implicating ERK/MAPK signaling as a partial, though not exclusive, contributor to the herb’s pro-osteogenic effect.

The pivotal step came when the team incorporated AB into bone organoid culture. Single-cell suspensions of stromal cells were seeded into ultra-low-attachment plates to form compact spheroids over three days, then embedded in growth factor-reduced Matrigel and cultured in osteogenic medium for 28 days, with 200 micrograms per milliliter AB added throughout maturation. Live/dead staining showed both groups remained viable, but AB-treated organoids displayed more widespread calcein-AM signal and reduced propidium iodide incorporation. Quantitative analysis demonstrated that AB-treated organoids achieved a larger cross-sectional area, suggesting accelerated tissue assembly and volumetric growth. Histological and matrix analyses confirmed the functional differences: AB-bone organoids exhibited stronger Alizarin Red S, alkaline phosphatase, and collagen type I staining, indicating enhanced calcium deposition, osteogenic enzyme activity, and extracellular matrix production, while immunofluorescence revealed more organized F-actin architecture and stronger Runx2 expression consistent with heightened osteogenic lineage activation.

Head-to-head comparison of monolayer cultures, untreated bone organoids, and AB-bone organoids revealed a stepwise enhancement in osteogenic output, with AB-bone organoids achieving the highest levels of enzymatic activity and matrix mineralization, accompanied by increased protein expression of COL-I, Runx2, and OPN and higher viability. The decisive test, however, came in vivo. In a critical-sized 5-millimeter calvarial defect model in adult rats, animals receiving AB-bone organoids showed more extensive defect bridging and denser mineralized tissue on micro-CT reconstructions at 12 weeks than those receiving untreated organoids or no implant. Quantitative analysis confirmed the most favorable bone microarchitecture in the AB-bone organoid group, with increased bone volume fraction, bone mineral density, trabecular thickness, and trabecular number, together with reduced trabecular separation. Histology showed greater bone fill and more organized collagen deposition, and immunohistochemistry revealed more abundant COL-I, OPN, and OCN-positive matrix within the regenerative area.

To explore clinical relevance, the team conducted a retrospective cohort study at Taizhou Hospital of Traditional Chinese Medicine, screening 126 consecutive tibial fracture patients operated on between January 2022 and December 2024, of whom 40 met eligibility criteria and were divided into 20 receiving oral AB beginning one month after surgery for six weeks and 20 receiving standard care. Baseline characteristics were well balanced between groups. Postoperative AB administration was associated with substantially shorter mean radiographic healing time of 3.8 versus 4.9 months, higher modified Radiographic Union Scale scores at final follow-up of 14.1 versus 12.3, lower pain scores of 1.3 versus 2.6 on the visual analogue scale, and superior lower-extremity function scores of 72.5 versus 65.2. Serial radiographs showed earlier callus formation and advanced remodeling in AB-treated patients, although the proportion achieving union by six months did not differ significantly.

The authors are careful to delineate the boundaries of these findings. The animal experiment evaluated localized implantation of AB-preconditioned organoids, while the clinical cohort evaluated systemic oral administration with entirely different pharmacokinetics, so the human data provide only indirect, hypothesis-generating support rather than evidence for the clinical feasibility of organoid implantation. Retrospective design cannot fully account for unmeasured confounding, and factors such as fracture severity, fixation characteristics, and rehabilitation compliance were not uniformly available. The calvarial model is non-load-bearing, vascularization was not directly quantified, the specific bioactive constituents responsible remain unidentified, and the ERK/MAPK experiments were conducted only in monolayer cells. Even so, the conceptual advance is considerable: a traditional osteoactive botanical factor has been repurposed as a developmental instruction for bone organoids, upgrading the therapeutic unit from isolated cells or soluble factors to an implantable living osteogenic microtissue, and defining a promising direction for biologically instructed bone regeneration that now awaits testing in load-bearing models, vascularized constructs, and eventually dedicated clinical trials.

Subject of Research: Achyranthes bidentata-functionalized bone marrow stromal cell-derived bone organoids for enhanced bone defect repair

Article Title: Achyranthes bidentata –functionalized bone organoids enhance bone defect repair

Article References: Lu, C., Qin, X., Lin, Z., Han, S., Ding, P., Xu, L., Zheng, X., Hu, B., Chen, F., & Wu, D. (2026). Achyranthes bidentata–functionalized bone organoids enhance bone defect repair. Materials Today Bio, 41, Article 103716. https://doi.org/10.1016/j.mtbio.2026.103716

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103716

Keywords: bone organoids, Achyranthes bidentata, bone regeneration, critical-sized defects, mesenchymal stromal cells, ERK/MAPK signaling, traditional Chinese medicine, calvarial defect model, fracture healing, osteogenesis, tissue engineering, Materials Today Bio